Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
TionLab Therapeutics logo — company profile

TionLab Therapeutics

Founded 2021 Seed Total: $1.44B Health and Wellness, Pharmaceutical

General Information

Company Name TionLab Therapeutics
Founded Year 2021
Industries Health and Wellness, Pharmaceutical
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with TionLab Therapeutics. To contact TionLab Therapeutics, visit tionlabrx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does TionLab Therapeutics compare?

A PDF of TionLab Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting TionLab Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About TionLab Therapeutics

TionLab Therapeutics is a pharmaceutical startup that was established in 2021. The company recently secured a Venture Round investment at 20 July 2023, with the Series Ventures as the primary investors. This investment underscores the confidence that Series Ventures has in TionLab Therapeutics' potential to make significant strides in the pharmaceutical industry. The backing from Series Ventures is a testament to TionLab Therapeutics' innovative approach and promising developments. As TionLab Therapeutics continues to establish its presence in the pharmaceutical sector, the recent investment infusion will undoubtedly facilitate the pursuit of its strategic objectives and enable the company to accelerate its research and development efforts. This will further bolster its position within the pharmaceutical industry, as it aims to bring novel and impactful therapies to the market. With this latest funding, TionLab Therapeutics is well-positioned to advance its mission of delivering groundbreaking solutions that address unmet medical needs. The support from Series Ventures not only provides financial backing but also signifies an endorsement of TionLab Therapeutics' vision and initiatives, setting the stage for the company's future growth and success.

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 1
Series Ventures
Series Ventures
20 Jul 2023
Seed Round KRW200.00M 1
블루포인트 (Bluepoint)
블루포인트 (Bluepoint)
22 Jul 2021
Seed Round KRW738.99M 1
Daewoong Pharmaceutical
Daewoong Pharmaceutical
14 Jul 2021
Seed Round KRW500.00M 1
E&Venture Partners
29 Jun 2021

FAQ About TionLab Therapeutics

TionLab Therapeutics was founded in 2021.
TionLab Therapeutics operates in Health and Wellness and Pharmaceutical.
TionLab Therapeutics has completed 4 funding rounds, raising a total of $1.44B. The latest funding stage is Seed.

We're actively collecting intelligence on TionLab Therapeutics.

Source: BounceWatch company record for TionLab Therapeutics, https://bouncewatch.com/company/tionlab-therapeutics, updated 11 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes